After eight years of research, two South African developed HIV vaccinesare to become the first African vaccines to undergo human clinicaltrials in the United States. The South African Aids Vaccine Initiative (SAAVI), which is a programmeof the Medical Research Council (MRC) and is supported by the SouthAfrican government, announced that the first phase of safety trialswill begin in Boston, USA this week. The vaccines were developed at the University of Cape Town's Institutefor Infectious...